Skip to main content
Caplight Logo









Genemod

Genemod

Private
Edmonds, WashingtonHealthcare & Life Scienceshttps://genemod.net

Last Round

Seed

May 4, 2023

Total Funding Raised

$6.2M

Company Overview

Genemod operates in Healthcare & Life Sciences and is based in Edmonds, Washington. Its latest recorded funding round was a Seed round in May 2023.

Genemod is a biotechnology software company that provides a cloud-based laboratory management platform for life science research and development teams.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Vertical SaaS, Workflow Automation, Document Management

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Genemod Comparables

Compare Genemod with similar companies based on industry and business-model similarity.

Genemod comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Labii Inc.
90%
Scispot
90%
Labric
86%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Genemod Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 4, 2023
SeedOct 13, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Jin Choe

CTO Co-Founder

Founding Team

Jacob Lee

Co-Founder CEO

Founding Team

For institutional investors. Book with your work email.

Genemod Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 8, 2026

    Added Niedenthal Emotions Lab as a customer.

  • Dec 8, 2025

    Genemod, Inc. has integrated with Third Wave Analytics, Inc. The partnership was announced in the article's title, but the article body provides no further details.

Book a demo to see all signals

For institutional investors. Book with your work email.

Genemod Filings

Explore SEC and related filing metadata, where available.

Genemod filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Genemod's valuation, stock price, and market status.

Is Genemod a public or private company?

Genemod is a private company.

What is the current stock price of Genemod?

Genemod is a private company, so its shares have no public market price. Caplight tracks Genemod's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Genemod worth (valuation)?

Valuation information for Genemod is not publicly available.

Can I buy Genemod stock?

Genemod shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Genemod's last funding round?

Genemod's most recent funding round was Seed on May 4, 2023.

Who are the main investors in Genemod?

Key investors in Genemod include Defy Partners Management, LDV Partners.

Will Genemod IPO soon?

No public IPO plans have been announced for Genemod.

How can I track Genemod secondary market activity?

Caplight tracks bids, offers, and trades in Genemod's shares on secondary markets.

Firmographic Details

HeadquartersEdmonds, Washington
Employee Range7
Year Founded2018
Last FundingMay 4, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?